Zobrazeno 1 - 10
of 33
pro vyhledávání: '"KYOHEI ARAKI"'
Autor:
Shintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, Kyohei Araki, Kensuke Mitsunari, Kojiro Ohba, Yasushi Mochizuki, Ryoichi Imamura
Publikováno v:
IJU Case Reports, Vol 7, Iss 4, Pp 324-328 (2024)
Introduction Few studies have reported on administering enfortumab vedotin to patients with metastatic urothelial carcinoma and end‐stage renal disease requiring hemodialysis. Case presentation Case 1: An 85‐year‐old man underwent hemodialysis
Externí odkaz:
https://doaj.org/article/d59e284047034cfba021b9c6b95466f2
Autor:
Masahito Masato, Yasuyoshi Miyata, Hiroki Kurata, Hidenori Ito, Kensuke Mitsunari, Akihiro Asai, Yuichiro Nakamura, Kyohei Araki, Yuta Mukae, Tsuyoshi Matsuda, Junki Harada, Tomohiro Matsuo, Kojiro Ohba, Hideki Sakai
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Prostaglandin E2 plays an important role in carcinogenesis and malignant potential of prostate cancer (PC) cells by binding to its specific receptors, E-type prostanoid (EP) receptors. However, anti-carcinogenic effects of the EP receptor an
Externí odkaz:
https://doaj.org/article/ea032fd4e6774aa8860e366a805ccd40
Autor:
Kyohei Araki, Yasuyoshi Miyata, Kojiro Ohba, Yuichiro Nakamura, Tomohiro Matsuo, Yasushi Mochizuki, Hideki Sakai
Publikováno v:
Medicines, Vol 7, Iss 11, p 71 (2020)
We, the authors, wish to make the following correction to our published paper [...]
Externí odkaz:
https://doaj.org/article/21bf01ca9422405da0181e151534e53d
Autor:
Kyohei Araki, Yasuyoshi Miyata, Kojiro Ohba, Yuichiro Nakamura, Tomohiro Matsuo, Yasushi Mochizuki, Hideki Sakai
Publikováno v:
Medicines, Vol 6, Iss 1, p 2 (2018)
Background: Although tyrosine kinase inhibitors (TKIs) are still recommended as the standard therapy in renal cell carcinoma (RCC), the high frequency of adverse events is a weakness of this therapy. Because royal jelly (RJ) possesses anti-inflammato
Externí odkaz:
https://doaj.org/article/469777019d9741fba50c31426e06c1d7
Autor:
Yasuyoshi Miyata, Tomohiro Matsuo, Kyohei Araki, Yuichiro Nakamura, Yuji Sagara, Kojiro Ohba, Hideki Sakai
Publikováno v:
Medicines, Vol 5, Iss 3, p 87 (2018)
Green tea and green tea polyphenols (GTPs) are reported to inhibit carcinogenesis and malignant behavior in several diseases. Various in vivo and in vitro studies have shown that GTPs suppress the incidence and development of bladder cancer. However,
Externí odkaz:
https://doaj.org/article/bed78af08b424e4e869a3cd77041a5e7
Autor:
SHINTARO MORI, TOMOHIRO MATSUO, HIROYUKI HONDA, KYOHEI ARAKI, KENSUKE MITSUNARI, KOJIRO OHBA, RYOICHI IMAMURA
Publikováno v:
In Vivo; Jul/Aug2024, Vol. 38 Issue 4, p2031-2040, 10p
Autor:
Yuta Mukae, Tsuyoshi Matsuda, Yuichiro Nakamura, Hidenori Ito, Hideki Sakai, Yasuyoshi Miyata, Tomohiro Matsuo, Kaname Ohyama, Nozomi Aibara, Kyohei Araki
Publikováno v:
Anticancer Research. 41:3815-3823
Background/aim A previous report showed that immune complex-ceruloplasmin (CP) in urine is associated with carcinogenesis and malignant behavior in bladder cancer (BC). We investigated the pathological significance and prognostic roles of urine and t
Autor:
Kojiro Ohba, Yasuyoshi Miyata, Hideki Sakai, Tsuyoshi Matsuda, Yuta Mukae, Yasushi Mochizuki, Tomohiro Matsuo, Yoshiaki Nagashima, Junki Harada, Kensuke Mistunari, Kyohei Araki
Publikováno v:
In Vivo
Background/aim The pathological significance of thrombospondin (TSP)-1 and -2 in bladder cancer (BC) is well-known whereas that of TSP-3, 4 and 5 remains unclear. Our aim is to clarify the pathological significance and prognostic roles of TSP-3 to 5
Autor:
Yasuyoshi Miyata, Hidenori Ito, Kojiro Ohba, Junki Harada, Tomohiro Matsuo, Hiroki Kurata, Hideki Sakai, Masahito Masato, Kensuke Mitsunari, Kyohei Araki, Yuichiro Nakamura, Yuta Mukae, Akihiro Asai, Tsuyoshi Matsuda
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Prostaglandin E2 plays an important role in carcinogenesis and malignant potential of prostate cancer (PC) cells by binding to its specific receptors, E-type prostanoid (EP) receptors. However, anti-carcinogenic effects of the EP receptor antagonist
Autor:
Yuji Sagara, Kensuke Mitsunari, Kyohei Araki, Yasushi Mochizuki, Tomohiro Matsuo, Kojiro Ohba, Hideki Sakai, Kaname Ohyama, Nozomi Aibara, Yasuyoshi Miyata
Publikováno v:
In Vivo
Background/aim Little is known on urine biomarkers that are associated with malignant behavior in patients with bladder cancer (BC). Our aim was to identify BC-related factors in urine samples using our original method "immune complexome analysis", b